Tagged: Neuronetics

STIM: Revenue Growth and Positive Adjusted EBITDA Give the Rally Substance

Neuronetics reported stronger third-quarter sales and positive adjusted EBITDA, while a GAAP loss and cash needs keep the turnaround unfinished.